일회용 EEG 전극 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the disposable EEG electrode market size was valued at USD 616 million in 2025 and is estimated to grow from USD 636.37 million in 2026 to reach USD 786.30 million by 2031, at a CAGR of 4.32% during the forecast period (2026-2031).

Global Disposable EEG Electrode Market Trends and Insights

Infection-Control Adoption of Single-Use Electrodes

Hospital infection-control policies are establishing a durable basis for demand in the Disposable EEG Electrode Market. The European Union Medical Devices Regulation restricts the reprocessing of single-use devices under Article 17, and national rules continue to guide implementation across member states. These requirements move purchasing decisions beyond clinician preference and place more weight on documented hygiene processes. The Australasian College for Infection Prevention and Control issued a 2025 position statement that addresses the use of single-use devices in infection-prevention practice. This environment supports patient-specific electrode kits in acute and semi-critical care workflows. The Disposable EEG Electrode Market also requires standardized pouching, traceability, and disposal instructions from suppliers.

Rising Neurological and Sleep-Disorder Monitoring Demand

Neurological care needs are expanding the potential monitoring pool for the Disposable EEG Electrode Market. The World Health Organization reported in 2025 that neurological conditions affect more than 3 billion people and account for more than 11 million deaths each year. The organization also reported that only 32% of member states had a national neurological policy, and only 25% included neurological services in universal health coverage benefit packages. These gaps limit access today, but they also create a need for wider diagnostic capacity as countries work toward the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022-2031. The World Health Organization states that around 50 million people live with epilepsy, with nearly 80% living in low- and middle-income countries. The Disposable EEG Electrode Market can support sleep studies, seizure monitoring, and outpatient neurological assessment with dependable consumables.

Higher Per-Procedure Cost Versus Reusable Electrodes

A visible per-procedure purchase cost remains a barrier for the Disposable EEG Electrode Market in price-sensitive settings. Hospitals and diagnostic centers that perform large volumes of neurological monitoring can see this cost accumulate across daily procedures. The issue is most acute in emerging markets, where reusable systems may have lower upfront supply costs and local alternatives can be less expensive. This creates different adoption conditions between facilities that prioritize infection control and labor efficiency and those focused mainly on procurement price. Bundled EEG kits and subscription-based supply programs can reduce ordering complexity, but their availability remains more established in North America and Western Europe. The Disposable EEG Electrode Market requires a clear workflow benefit and predictable supply terms in high-volume facilities with constrained budgets.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of Point-of-Care and Ambulatory EEG
2. Disposable Electrode Integration With AI-Enabled EEG Workflows
3. Regulatory and Clinical Validation Complexity

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Wet EEG electrodes accounted for 57.8% of the Disposable EEG Electrode Market share in 2025. Their position reflects established use in hospital laboratories and inpatient monitoring units, where trained technicians can apply conductive gel. Wet electrodes continue to set the signal-quality benchmark in controlled clinical workflows. Pre-gelled products improve the setup process while preserving the operating principles familiar to EEG staff. Needle electrodes serve intraoperative applications where scalp access is restricted. Patch and adhesive electrodes are useful for neonatal and pediatric monitoring where conventional cup placement may be impractical. Disposable caps, headbands, and accessories serve narrower requirements across research, acute care, and specialized monitoring.

Dry EEG electrodes are projected to record a 5.3% CAGR through 2031, making them the fastest-growing product category. Their growth reflects compatibility with home monitoring, ambulatory epilepsy assessment, and brain-computer interface use cases that require self-application. A 2025 study reported that a PEDOT:PSS/PVA-coated fabric dry electrode achieved contact impedance and EEG signal quality comparable to Ag/AgCl wet electrodes after 10 washing cycles . This evidence supports the technical direction of dry wearable formats, but clinical adoption still depends on validation and regulatory clearance. Home use is likely to develop before widespread replacement of wet systems in complex diagnostic laboratories. The Disposable EEG Electrode Market can benefit from products that improve adhesion, instructions, and comfort for patients without a technician.

Silver/silver chloride electrodes held 68.3% of market share in 2025. Their long clinical history, biocompatibility profile, and available manufacturing scale support continued use across established EEG procedures. Gel-assisted Ag/AgCl systems remain familiar to clinicians and are used as a reference point for signal performance. Gold electrodes serve select research and premium applications where material characteristics and longer-term use matter. Stainless steel electrodes address specialized settings, including some intraoperative procedures. Carbon-based materials are being examined for wearable electrodes because they can combine electrical performance with mechanical flexibility. These material choices give suppliers a way to tailor products to clinical, research, and portable monitoring requirements.

Conductive polymer materials are forecast to grow at a 5.2% CAGR through 2031. PEDOT:PSS-based designs can support stretchability, gel-free operation, and integration with textiles. These features enable electrode formats that are harder to create with conventional metal-foil designs. A 2025 study of MXene/PEDOT:PSS epidermal dry electrodes reported high conductivity and strain-insensitive performance for physiological signal monitoring. The development path for polymer materials is therefore tied to wearable monitoring and extended-use comfort. Suppliers still need biocompatibility evidence and suitable regulatory documentation before these materials can enter broad clinical use. The Disposable EEG Electrode Market can retain Ag/AgCl as its clinical base while polymer technologies expand into differentiated applications.

Cup electrodes held 33.4% of global disposable EEG electrode sales in 2025. Their use is closely linked to the international 10-20 EEG placement system used in standard clinical recording montages. This relationship supports continued demand in neurology departments because alternative forms must demonstrate clinical equivalence in established workflows. Needle electrodes address intraoperative settings where ordinary scalp placement is not suitable. Patch and disk electrodes offer different attachment methods for neonatal, ambulatory, and focused monitoring applications. The diversity of form factors reflects the need to match electrode design to patient condition, recording duration, and care setting. It also reduces the likelihood that one design will displace every other category.

Electrode arrays are forecast to expand at a 5.1% CAGR through 2031. High-density recording needs in neurocritical care, intraoperative monitoring, rehabilitation, and brain-computer interface applications support this growth. Ceribell uses a 10-electrode headband array designed for rapid placement in critical care settings. Arrays reduce the time needed to place individual electrodes while preserving multi-site recording capability. Headbands, caps, and nets also fit research and consumer-facing brain-computer interface applications where self-application is important. The 2025 REVE foundation model was trained on 60,000 hours of EEG data from 92 datasets and 25,000 subjects, showing support for varied electrode layouts in model development. This work supports flexible layouts, although clinical users still need formats that fit validated care protocols.

Complete Report Scope:

• Segmentation by Product Type
  • Wet EEG Electrodes
  • Dry EEG Electrodes
  • Needle EEG Electrodes
  • Patch and Adhesive EEG Electrodes
  • Disposable EEG Caps and Headbands
  • Electrode Accessories
• Segmentation by Material Type
  • Silver/Silver Chloride
  • Gold
  • Stainless Steel
  • Conductive Polymer
  • Carbon-Based and Other Materials
• Segmentation by Form Factor
  • Cup Electrodes
  • Needle Electrodes
  • Patch Electrodes
  • Disk Electrodes
  • Headbands, Caps and Nets
  • Electrode Arrays
• Segmentation by Channel Configuration
  • Single-Channel Electrodes
  • Multi-Channel Electrode Arrays
• Segmentation by Application
  • Clinical Diagnostics
  • Sleep Studies
  • Neurocritical Care
  • Intraoperative Monitoring
  • Brain-Computer Interface Applications
  • Others
• Segmentation by End User
  • Hospitals and Neurology Clinics
  • Diagnostic and Sleep Centers
  • Ambulatory Surgical and Outpatient Centers
  • Academic and Research Institutes
  • Pharmaceutical and Contract Research Organizations
  • Home Healthcare and Remote Monitoring Providers
• Segmentation by Distribution Channel
  • Direct Sales
  • Medical Device Distributors
  • Hospital Group Purchasing Organizations
  • Online and Manufacturer Stores
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East and africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 42.7% of global disposable EEG electrode sales in 2025. The region benefits from established hospital utilization, FDA clearance activity, and group purchasing arrangements that support disposable consumables. The United States is the primary source of regional demand because of its concentration of epilepsy monitoring units and broader acute-care infrastructure. Natus received FDA 510(k) clearance in December 2025 for a BrainWatch electrographic status epilepticus indication, supporting point-of-care EEG use in acute-care settings. The company also reported Medicare New Technology Add-on Payment eligibility with a maximum incremental payment of USD 913.9 per eligible patient for the solution. Canada and Mexico represent smaller but developing demand centers. Covenant Health published a 2025 policy covering standards for single-use medical devices, illustrating the infection-prevention focus in Canadian health care.

Europe is the second-largest regional market for the Disposable EEG Electrode Market. Germany, France, the United Kingdom, Italy, and Spain are the principal demand centers. Germany's aging population supports neurological monitoring needs because the frequency of stroke, dementia, and Parkinson's disease rises with age. EU Medical Devices Regulation requirements establish a strong compliance framework for single-use device practices across the region. This framework increases the operational importance of validated handling and reprocessing where reusable electrodes are used. France has favorable conditions for growth as awareness of neurological disorders and health care investment increase. Regional suppliers can differentiate by addressing compliance documentation, patient-specific packaging, and MRI-conditional product requirements.

Asia-Pacific is forecast to grow at a 5.8% CAGR through 2031, the fastest regional rate in the Disposable EEG Electrode Market. China supports regional volume growth through domestic production for local health care facilities and export markets. Japan's focus on AI-integrated diagnostic systems supports demand for rapid neurological assessment in an aging population. India and South Korea offer growth potential through diagnostic infrastructure investment and advanced hospital technology adoption, respectively. Price sensitivity in lower-tier hospitals and some Southeast Asian markets remains a constraint because disposable products compete with lower-cost reusable alternatives. The Middle East and Africa and South America contribute smaller shares, with GCC countries, South Africa, Brazil, and Argentina providing key demand centers. Private hospital networks in Brazil and Argentina are important adopters of premium single-use electrode formats.

1. Natus Medical
2. Ambu
3. Nihon Kohden
4. Medtronic
5. Rhythmlink International, LLC
6. Cadwell
7. Koninklijke Philips
8. Conmed
9. Compumedics
10. Brain Products GmbH
11. BIOPAC Systems, Inc.
12. Ceribell, Inc.
13. Brain Scientific Inc.
14. NeuroWave Systems
15. Micromed S.p.A.
16. Neurosoft
17. Bittium Biosignals Ltd
18. Dymedix Diagnostics
19. SPES MEDICA S.r.l.
20. B. Braun

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Infection-Control Adoption of Single-Use Electrodes
  • 4.2.2 Rising Neurological and Sleep-Disorder Monitoring Demand
  • 4.2.3 Expansion of Point-of-Care and Ambulatory EEG
  • 4.2.4 Faster Setup Through Pre-Gelled and Integrated Electrode Systems
  • 4.2.5 Disposable Electrode Integration With AI-Enabled EEG Workflows
  • 4.2.6 Contract-Based Procurement of Patient-Specific EEG Kits
• 4.3 Market Restraints
  • 4.3.1 Higher Per-Procedure Cost Versus Reusable Electrodes
  • 4.3.2 Regulatory and Clinical Validation Complexity
  • 4.3.3 Electrode-Skin Impedance and Motion-Artifact Variability
  • 4.3.4 Medical Waste and Silver-Containing Material Disposal Burden
• 4.4 Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porters Five Forces Analysis
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS

• 5.1 Segmentation by Product Type
  • 5.1.1 Wet EEG Electrodes
  • 5.1.2 Dry EEG Electrodes
  • 5.1.3 Needle EEG Electrodes
  • 5.1.4 Patch and Adhesive EEG Electrodes
  • 5.1.5 Disposable EEG Caps and Headbands
  • 5.1.6 Electrode Accessories
• 5.2 Segmentation by Material Type
  • 5.2.1 Silver/Silver Chloride
  • 5.2.2 Gold
  • 5.2.3 Stainless Steel
  • 5.2.4 Conductive Polymer
  • 5.2.5 Carbon-Based and Other Materials
• 5.3 Segmentation by Form Factor
  • 5.3.1 Cup Electrodes
  • 5.3.2 Needle Electrodes
  • 5.3.3 Patch Electrodes
  • 5.3.4 Disk Electrodes
  • 5.3.5 Headbands, Caps and Nets
  • 5.3.6 Electrode Arrays
• 5.4 Segmentation by Channel Configuration
  • 5.4.1 Single-Channel Electrodes
  • 5.4.2 Multi-Channel Electrode Arrays
• 5.5 Segmentation by Application
  • 5.5.1 Clinical Diagnostics
  • 5.5.2 Sleep Studies
  • 5.5.3 Neurocritical Care
  • 5.5.4 Intraoperative Monitoring
  • 5.5.5 Brain-Computer Interface Applications
  • 5.5.6 Others
• 5.6 Segmentation by End User
  • 5.6.1 Hospitals and Neurology Clinics
  • 5.6.2 Diagnostic and Sleep Centers
  • 5.6.3 Ambulatory Surgical and Outpatient Centers
  • 5.6.4 Academic and Research Institutes
  • 5.6.5 Pharmaceutical and Contract Research Organizations
  • 5.6.6 Home Healthcare and Remote Monitoring Providers
• 5.7 Segmentation by Distribution Channel
  • 5.7.1 Direct Sales
  • 5.7.2 Medical Device Distributors
  • 5.7.3 Hospital Group Purchasing Organizations
  • 5.7.4 Online and Manufacturer Stores
• 5.8 By Geography
  • 5.8.1 North America
    • 5.8.1.1 United States
    • 5.8.1.2 Canada
    • 5.8.1.3 Mexico
  • 5.8.2 Europe
    • 5.8.2.1 Germany
    • 5.8.2.2 United Kingdom
    • 5.8.2.3 France
    • 5.8.2.4 Italy
    • 5.8.2.5 Spain
    • 5.8.2.6 Rest of Europe
  • 5.8.3 Asia-Pacific
    • 5.8.3.1 China
    • 5.8.3.2 Japan
    • 5.8.3.3 India
    • 5.8.3.4 South Korea
    • 5.8.3.5 Australia
    • 5.8.3.6 Rest of Asia-Pacific
  • 5.8.4 Middle East and africa
    • 5.8.4.1 GCC
    • 5.8.4.2 South Africa
    • 5.8.4.3 Rest of Middle East and Africa
  • 5.8.5 South America
    • 5.8.5.1 Brazil
    • 5.8.5.2 Argentina
    • 5.8.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 Natus Medical Incorporated
  • 6.3.2 Ambu A/S
  • 6.3.3 NIHON KOHDEN CORPORATION
  • 6.3.4 Medtronic plc
  • 6.3.5 Rhythmlink International, LLC
  • 6.3.6 Cadwell Industries, Inc.
  • 6.3.7 Koninklijke Philips N.V.
  • 6.3.8 CONMED Corporation
  • 6.3.9 Compumedics Limited
  • 6.3.10 Brain Products GmbH
  • 6.3.11 BIOPAC Systems, Inc.
  • 6.3.12 Ceribell, Inc.
  • 6.3.13 Brain Scientific Inc.
  • 6.3.14 NeuroWave Systems Inc.
  • 6.3.15 Micromed S.p.A.
  • 6.3.16 Neurosoft
  • 6.3.17 Bittium Biosignals Ltd
  • 6.3.18 Dymedix Diagnostics
  • 6.3.19 SPES MEDICA S.r.l.
  • 6.3.20 B. Braun Melsungen AG

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-Space and Unmet-Need Assessment